Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial

作者
Tracy L. Stockley,Amit M. Oza,Hal K. Berman,Natasha B. Leighl,Jennifer Jane Knox,Frances A. Shepherd,Eric Xueyu Chen,Monika Karolina Krzyzanowska,Neesha C. Dhani,Anthony Michael Joshua,Ming‐Sound Tsao,Stefano Serra,Blaise Alexander Clarke,Michael H. A. Roehrl,Tong Zhang,Mahadeo A. Sukhai,Nadia Califaretti,Mateya Trinkaus,Patricia H. Shaw,Theodorus van der Kwast
出处
期刊:Genome Medicine [BioMed Central]
卷期号:8 (1): 109-109 被引量:277
标识
DOI:10.1186/s13073-016-0364-2
摘要

BACKGROUND: The clinical utility of molecular profiling of tumor tissue to guide treatment of patients with advanced solid tumors is unknown. Our objectives were to evaluate the frequency of genomic alterations, clinical "actionability" of somatic variants, enrollment in mutation-targeted or other clinical trials, and outcome of molecular profiling for advanced solid tumor patients at the Princess Margaret Cancer Centre (PM). METHODS: Patients with advanced solid tumors aged ≥18 years, good performance status, and archival tumor tissue available were prospectively consented. DNA from archival formalin-fixed paraffin-embedded tumor tissue was tested using a MALDI-TOF MS hotspot panel or a targeted next generation sequencing (NGS) panel. Somatic variants were classified according to clinical actionability and an annotated report included in the electronic medical record. Oncologists were provided with summary tables of their patients' molecular profiling results and available mutation-specific clinical trials. Enrolment in genotype-matched versus genotype-unmatched clinical trials following release of profiling results and response by RECIST v1.1 criteria were evaluated. RESULTS: From March 2012 to July 2014, 1893 patients were enrolled and 1640 tested. After a median follow-up of 18 months, 245 patients (15 %) who were tested were subsequently treated on 277 therapeutic clinical trials, including 84 patients (5 %) on 89 genotype-matched trials. The overall response rate was higher in patients treated on genotype-matched trials (19 %) compared with genotype-unmatched trials (9 %; p < 0.026). In a multi-variable model, trial matching by genotype (p = 0.021) and female gender (p = 0.034) were the only factors associated with increased likelihood of treatment response. CONCLUSIONS: Few advanced solid tumor patients enrolled in a prospective institutional molecular profiling trial were treated subsequently on genotype-matched therapeutic trials. In this non-randomized comparison, genotype-enrichment of early phase clinical trials was associated with an increased objective tumor response rate. TRIAL REGISTRATION: NCT01505400 (date of registration 4 January 2012).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LW3366完成签到,获得积分10
刚刚
ding的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得30
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
慕青的应助被科研通管家采纳,获得10
2秒前
科研通AI2S的应助被科研通管家采纳,获得10
2秒前
李爱国的应助被科研通管家采纳,获得10
2秒前
2秒前
李爱国的应助被科研通管家采纳,获得10
2秒前
2秒前
无极微光的应助被科研通管家采纳,获得20
2秒前
DW的应助被科研通管家采纳,获得10
2秒前
勤奋一一的应助被科研通管家采纳,获得10
2秒前
3秒前
wanci的应助被科研通管家采纳,获得10
3秒前
传奇3的应助被科研通管家采纳,获得10
3秒前
搜集达人的应助被科研通管家采纳,获得10
3秒前
隐形曼青的应助被科研通管家采纳,获得10
3秒前
剪刀手发布了新的文献求助10
3秒前
研友_VZG7GZ的应助被gentle采纳,获得10
3秒前
ding的应助被科研通管家采纳,获得10
3秒前
sheey的应助被科研通管家采纳,获得30
3秒前
香蕉觅云的应助被科研通管家采纳,获得10
3秒前
杜欣悦完成签到,获得积分20
3秒前
coolru的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
段旭乐的应助被科研通管家采纳,获得10
4秒前
李爱国的应助被科研通管家采纳,获得20
4秒前
4秒前
852的应助被MADAO采纳,获得30
4秒前
去偷火龙果完成签到,获得积分10
4秒前
学术小白发布了新的文献求助10
5秒前
6秒前
wsy完成签到,获得积分10
6秒前
peir完成签到,获得积分10
7秒前
科研努力版完成签到 ,获得积分10
8秒前
风吹麦浪发布了新的文献求助10
8秒前
9秒前
小二郎的应助被嗷嗷ao采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621